SCHEMBL22967641

SCHEMBL22967641

CC(C)(C)N1CCN(C(=O)/C=C/CF)C(CC#N)C1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KRAS P01116 2/20 0.37
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24854345 1.00 KRAS (0.37) KRASDPP4
SCHEMBL22967640 1.00 KRAS (0.37) KRASDPP4
SCHEMBL22967484 0.86
SCHEMBL22967478 0.86
SCHEMBL22967772 0.86 JAK3 (0.32)
SCHEMBL22967932 0.85 ELANE (0.37) KRAS
SCHEMBL22967775 0.84 ELANE (0.38)
SCHEMBL24543364 0.84 KRAS (0.38) KRASDPP4
SCHEMBL22967639 0.83 KRAS (0.30) KRAS
SCHEMBL22967504 0.82 KRAS (0.38) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS KRAS, NRAS, APC KRAS 1/4885DPP4 3172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.